Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Clindamycin und Benzoylperoxid, ATC D10AF54

Health · Germany government procurement

Closed April 30, 2027. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredients clindamycin and benzoyl peroxide, ATC D10AF54

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryPharmaceuticals
PublishedMay 19, 2025
Procurement stageActive solicitation
ClosedApril 30, 2027
StatusClosed — no longer accepting responses
TranslationTranslated from German by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Browse Similar Open Opportunities in Germany

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Kaliumiodid, ATC H03CA01 für die Zeit 01.03.2026 - 29.02.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-20 - Pegfilgrastim
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Perindopril und Amlodipin, ATC C09BB04 für die Zeit 01.04.2025 - 31.03.2027
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Glyceroltrinitrat (ATC-Code nach WHO: C01DA02)
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Opipramol, ATC N06AA05
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tobramycin, ATC J01GB01
Germany – Pharmaceutical products – Arzneimittel mit der Wirkstoffkombination Brinzolamid und Timolol (ATC: S01ED67)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Everolimus, ATC L04AH02 für die Zeit 01.02.2026 - 31.01.2028 (zzgl. Verlängerungsoption 1x12 Monate)

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.